Funder: National Institutes of Health
Due Dates: November 5, 2026 (Renewal/Resubmission/Revision) | February 5, 2027 (New) | March 5, 2027 (Renewal/Resubmission/Revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/Resubmission/Revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/Resubmission/Revision) | January 7, 2028 (Closing)
Funding Amounts: Up to $499,000 in direct costs annually for up to 5 years; no cost sharing required
Summary: Supports academic-industrial partnerships translating technologies into usable tools for disease research, risk assessment, diagnosis, treatment, and monitoring.
Key Information: Each partnership must include at least one academic and one industrial organization; clinical trials are not allowed.
Description
This NIH R01 program supports interdisciplinary, multi-institutional teams translating scientific discoveries and engineering developments into capabilities useful to end users. Participating institutes are the National Cancer Institute, National Eye Institute, and National Institute of Dental and Craniofacial Research. The Office of Research on Women’s Health may co-fund relevant awards.
Projects may enhance, adapt, optimize, or validate technologies, methods, assays, devices, and systems for preclinical research, clinical research, care delivery, or nonclinical research. Examples include molecular diagnostics, imaging, spectroscopy, informatics, artificial intelligence, platform harmonization, and shared validation resources. The emphasis is on moving beyond demonstration of possibility toward practical use and sustainable dissemination. Innovation is defined as the likelihood of delivering a new capability to end users, rather than technological novelty alone.
